Article Text

Download PDFPDF
Original article
A novel procedure for treating canalicular obstruction by re-canaliculisation and bicanalicular intubation
  1. Dong Chen1,2,
  2. Naiyang Li2,
  3. Pengxia Wan2,
  4. Jianhui Xiao2,
  5. Ying Liu2,
  6. Xiaoran Wang2,
  7. Zhichong Wang2
  1. 1Department of E.N.T, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, The People's Republic of China
  2. 2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, The People's Republic of China
  1. Correspondence to Dr Zhichong Wang, Zhongshan Ophthalmic Centre, Sun Yat-sen University, N0.54 S Xianlie Road, Guangzhou 510060, P.R. The People's Republic of China; wzc001{at}hotmail.com

Abstract

Aim The aim of this study was to evaluate a new procedure for treating canalicular obstruction by re-canaliculisation and bicanalicular intubation (RC-BCI).

Methods Thirty adult patients (32 eyes) with canalicular obstruction were treated with RC-BCI from September 2005 to December 2007 at Zhongshan Ophthalmic Centre (Guangzhou, China). Silicone tubes were left in place for 2–3 months and were removed when patients had relief by tearing. Patients were evaluated postoperatively by symptoms, lacrimal irrigation and satisfaction rate.

Results Mean follow-up time after tube removal was 21.5 (range 6–26) months. Twenty-six eyes (81.25%) had complete epiphora relief, two eyes (6.25%) had partial relief and four eyes (12.5%) had no improvement after the removal of the tubes. One eye (3.13%) had lower punctum splitting 2 months after the surgery. The overall satisfaction rate was 93.3% in 30 patients. No other complications occurred.

Conclusion Our findings demonstrated that the RC-BCI was an effective procedure for treating canalicular obstruction with few complications.

  • Lacrimal drainage
  • treatment surgery
  • tears
  • rehabilitation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • NL and DC contributed equally to the work and should be considered equivalent first authors.

  • Funding This work was supported by grant No. 30973246 (WZC) from National Natural Science Foundation of China.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval This study was approved by Institutional Review Board (IRB)/Ethics Committee of Zhongshan Ophthalmic Centre, Sun Yat-sen University.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh